(VCYT) Veracyte - Performance 29.7% in 12m
VCYT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-13.55%
#39 in Peer-Group
Rel. Strength
75.30%
#1905 in Stock-Universe
Total Return 12m
29.73%
#42 in Peer-Group
Total Return 5y
-3.50%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 65.9 |
| P/E Forward | 20.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 46.14 USD |
| 52 Week Low | 21.00 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 67.54 |
| Buy/Sell Signal +-5 | 0.24 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VCYT (29.7%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: VCYT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VCYT
| Total Return (including Dividends) | VCYT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.14% | 4.38% | 4.99% |
| 3 Months | -8.46% | 5.22% | 10.23% |
| 12 Months | 29.73% | -7.16% | 14.42% |
| 5 Years | -3.50% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | VCYT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -3.8% | 3.5% | 79.1% |
| 3 Months | -80.3% | 75.7% | 95.5% |
| 12 Months | -4.1% | -85.1% | 44.7% |
| 5 Years | -37.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th56.00 | -1.19% | -1.76% |
| 3 Month | %th35.00 | -13.00% | -16.96% |
| 12 Month | %th80.00 | 39.73% | 13.38% |
| 5 Years | %th82.50 | 28.00% | -54.09% |
FAQs
Does Veracyte (VCYT) outperform the market?
Yes,
over the last 12 months VCYT made 29.73%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months VCYT made -8.46%, while XBI made 5.22%.
Performance Comparison VCYT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VCYT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.1% | -1.9% | -38.6% | 15% |
| US NASDAQ 100 | QQQ | 2.5% | -2.3% | -40% | 16% |
| German DAX 40 | DAX | 3.1% | 3.7% | -50.1% | -1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.8% | -1% | -39% | 12% |
| Hongkong Hang Seng | HSI | 4% | -4% | -57.1% | -7% |
| India NIFTY 50 | INDA | 3.2% | 1.2% | -35.9% | 30% |
| Brasil Bovespa | EWZ | -0.6% | -4.9% | -61.5% | 16% |
VCYT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.1% | -2.6% | -42.9% | 3% |
| Consumer Discretionary | XLY | 1% | 0.3% | -31.7% | 11% |
| Consumer Staples | XLP | 1.8% | 3.3% | -38% | 20% |
| Energy | XLE | 1.4% | -3% | -33.7% | 31% |
| Financial | XLF | 1.9% | -0.4% | -41.7% | 2% |
| Health Care | XLV | 3.2% | 0.7% | -31% | 34% |
| Industrial | XLI | 1.2% | -1.1% | -45.3% | 6% |
| Materials | XLB | -1% | -2.7% | -42.8% | 23% |
| Real Estate | XLRE | 2.9% | 2.3% | -37.1% | 17% |
| Technology | XLK | 2.6% | -5.9% | -41.5% | 18% |
| Utilities | XLU | 3.4% | 3.6% | -39.8% | 7% |
| Aerospace & Defense | XAR | 1.9% | -4.4% | -56.9% | -19% |
| Biotech | XBI | 2.4% | -1.2% | -24.5% | 37% |
| Homebuilder | XHB | -2.8% | -8.5% | -32.5% | 24% |
| Retail | XRT | -0.6% | -2.4% | -33.4% | 19% |
VCYT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.2% | -5.54% | -30.1% | 37% |
| Natural Gas | UNG | 7% | 11.7% | -22.5% | 36% |
| Gold | GLD | 3.6% | 3.9% | -57.8% | -14% |
| Silver | SLV | 3.6% | -2.1% | -55.2% | 6% |
| Copper | CPER | -0.2% | -3% | -59.1% | 13% |
VCYT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.8% | -0.1% | -34% | 29% |
| iShares High Yield Corp. Bond | HYG | 3.6% | 1.2% | -36.6% | 19% |